- Home
- IQV vs FCNCA Comparison
IQV vs FCNCA Comparison
Compare IQV & FCNCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IQV
- FCNCA
- Stock Information
- Founded
- IQV 1982
- FCNCA 1898
- Country
- IQV United States
- FCNCA United States
- Employees
- IQV N/A
- FCNCA N/A
- Industry
- IQV Biotechnology: Commercial Physical & Biological Resarch
- FCNCA Major Banks
- Sector
- IQV Health Care
- FCNCA Finance
- Exchange
- IQV Nasdaq
- FCNCA Nasdaq
- Market Cap
- IQV 26.7B
- FCNCA 25.4B
- IPO Year
- IQV 2013
- FCNCA N/A
- Fundamental
- Price
- IQV $136.91
- FCNCA $1,822.27
- Analyst Decision
- IQV Buy
- FCNCA Buy
- Analyst Count
- IQV 20
- FCNCA 9
- Target Price
- IQV $226.80
- FCNCA $2,420.44
- AVG Volume (30 Days)
- IQV 2.6M
- FCNCA 76.7K
- Earning Date
- IQV 05-06-2025
- FCNCA 04-24-2025
- Dividend Yield
- IQV N/A
- FCNCA 0.43%
- EPS Growth
- IQV 0.26
- FCNCA N/A
- EPS
- IQV 7.35
- FCNCA 175.01
- Revenue
- IQV $15,497,000,000.00
- FCNCA $9,091,000,000.00
- Revenue This Year
- IQV $5.40
- FCNCA N/A
- Revenue Next Year
- IQV $5.21
- FCNCA $2.30
- P/E Ratio
- IQV $18.65
- FCNCA $10.41
- Revenue Growth
- IQV 2.84
- FCNCA N/A
- 52 Week Low
- IQV $134.65
- FCNCA $1,473.62
- 52 Week High
- IQV $252.88
- FCNCA $2,412.93
- Technical
- Relative Strength Index (RSI)
- IQV 36.95
- FCNCA 46.55
- Support Level
- IQV $137.34
- FCNCA $1,772.29
- Resistance Level
- IQV $145.78
- FCNCA $1,977.80
- Average True Range (ATR)
- IQV 5.73
- FCNCA 35.90
- MACD
- IQV -0.53
- FCNCA -7.69
- Stochastic Oscillator
- IQV 10.35
- FCNCA 23.88
About IQV IQVIA Holdings Inc.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
About FCNCA First Citizens BancShares Inc.
First Citizens BancShares Inc is the bank holding company of First Citizens Bank and Trust Company. The company's segments include the General Bank, the Commercial Bank, SVB Commercial, and Rail. The General Bank segment delivers products and services to consumers and businesses through our extensive network of branches and various digital channels. The Commercial Bank segment provides financial services, including lending, leasing, and advisory, to small and mid-market businesses across various industries. The SVB Commercial provides financial services to innovators, investors, and venture firms. The Rail segment provides tailored leasing and financing for railcars and locomotives across North America. It generates the majority of its revenue from the General Banking segment.